M&A | Partnerships

June 21, 2022

Bioventus Amends CartiHeal Acquisition Structure

Bioventus Amends CartiHeal Acquisition Structure
The amended agreement reduces the closing payment to $50 million (plus $50 million deposited into escrow last year) from the original $315 million.
April 25, 2022

ORHub Acquires PUR Biologics

ORHub Acquires PUR Biologics
ORHub will enter the medical device market with biologics to regenerate cartilage and address degenerative disc disease and osteoarthritis.
April 5, 2022

TheraCell Acquired by Isto Biologics

TheraCell Acquired by Isto Biologics
The move will expand Isto's portfolio of procedure-specific allografts for spine, orthopedic and sports medicine applications.